Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea
about
Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrierRole of Oxidative Stress in the Neurocognitive Dysfunction of Obstructive Sleep Apnea SyndromeMonoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.The polymorphic and contradictory aspects of intermittent hypoxiaGrowth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse.Alzheimer's disease, sleep apnea, and positive pressure therapyTreatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to agingNovel pharmacological approaches for treatment of obstructive sleep apnea in children.Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity.Evaluation of the predictive value of red blood cell distribution width for onset of cerebral infarction in the patients with obstructive sleep apnea hypopnea syndromeCritical Role of Endoplasmic Reticulum Stress in Chronic Intermittent Hypoxia-Induced Deficits in Synaptic Plasticity and Long-Term MemoryLong-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats.A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD.Factors related to pediatric obstructive sleep apnea-hypopnea syndrome in children with attention deficit hyperactivity disorder in different age groups.Intermittent Hypoxia Does not Elicit Memory Impairment in Spinal Cord Injury Patients.
P2860
Q26849304-BA59A3FD-2A24-4998-8E58-B5D1E0CDD146Q28066757-58CCC1B5-4D7F-450B-8674-B484DC747E9FQ33784147-6E20F517-689B-4C07-9141-66C66B98140EQ33913792-9CF7E790-38B1-4A89-8380-2B90F192A2AFQ37364745-91730CCB-CF6E-4DE8-831C-02F729EA0306Q37540111-440C431E-5454-4FFD-B4EF-03749CAB09A0Q37565965-861F02F5-5ECC-499A-B6CA-DB906A3210CEQ38057797-2631A667-EA2C-4BBD-BB67-35131BDFA3E3Q38118901-C9A64203-1540-4056-8E2F-0347E9256174Q39413926-930B7793-251E-44F2-A179-F82E0C1A1940Q41090861-B5FA18FA-E5D4-4911-8AB4-442B74A73C1EQ42217838-B73CECF9-796C-4FEF-8C99-7808B5276EA3Q45976217-A06FD83A-182D-497E-B516-31C755604118Q46256199-ACBACB0B-E277-4757-A548-C12E0233125DQ47094410-0CB5700C-CD2C-43A3-B414-999DEDC92695Q50519926-01EEEE9A-B594-4B0C-9063-5D62DA416A71
P2860
Exogenous erythropoietin administration attenuates intermittent hypoxia-induced cognitive deficits in a murine model of sleep apnea
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@ast
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@en
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@nl
type
label
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@ast
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@en
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@nl
prefLabel
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@ast
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@en
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@nl
P2093
P2860
P356
P1433
P1476
Exogenous erythropoietin admin ...... a murine model of sleep apnea
@en
P2093
Ehab A Dayyat
Shelley X Zhang
Zixi Jack Cheng
P2860
P2888
P356
10.1186/1471-2202-13-77
P50
P577
2012-07-03T00:00:00Z
P5875
P6179
1033868953